MedPath

Developing a new test for liver injury after taking too much paracetamol

Not Applicable
Conditions
Diagnosis of liver injury in patients presenting with paracetamol overdose
Injury, Occupational Diseases, Poisoning
Poisoning by nonopioid analgesics, antipyretics and antirheumatics
Registration Number
ISRCTN11484200
Lead Sponsor
Accord (United Kingdom)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
620
Inclusion Criteria

1. Presentation at hospital within 5 days after suspected or confirmed paracetamol overdose (all patterns of overdose are eligible – including single and staggered overdoses whether accidental or deliberate)
2. Aged 16 years or older
3. Capacity to provide informed consent
4. Deemed suitable for study procedures by attending/treating clinician

Exclusion Criteria

1. Deemed unfit by the Investigator or treating clinician to participate
2. Detained under the Mental Health (Care and Treatment) (Scotland) Act 2003

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. ALT measured as part of routine clinical care and recorded on the patient’s electronic medical record (daily blood results will be recorded up until day 30)<br> 2. K18 in finger prick capillary blood measured using the Point of Care DILI Diagnostic (lateral flow assay combined with handheld Raman Spectrometer) at baseline, +2 hours then daily for up to 5 days whilst the participant is in hospital<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. ALT, INR and bilirubin measured as part of routine clinical care and recorded on the patient’s electronic medical record (daily blood results will be recorded up until day 30)<br> 2. K18 from surplus blood serum measured by ELISA using the M65 Classic ELISA on days 1 and 2 if the participant is admitted and is in hospital on those days<br>
© Copyright 2025. All Rights Reserved by MedPath